Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Long-Term Investments (2018 - 2023)

Arrowhead Pharmaceuticals' Long-Term Investments history spans 12 years, with the latest figure at $42.8 million for Q2 2023.

  • For Q2 2023, Long-Term Investments fell 74.2% year-over-year to $42.8 million; the TTM value through Jun 2023 reached $42.8 million, down 74.2%, while the annual FY2022 figure was $105.9 million, 56.89% down from the prior year.
  • Long-Term Investments reached $42.8 million in Q2 2023 per ARWR's latest filing, down from $78.8 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $245.6 million in Q3 2021 to a low of $26.3 million in Q4 2019.
  • Average Long-Term Investments over 5 years is $122.9 million, with a median of $113.4 million recorded in 2020.
  • Peak YoY movement for Long-Term Investments: soared 321.67% in 2020, then tumbled 74.2% in 2023.
  • A 5-year view of Long-Term Investments shows it stood at $26.3 million in 2019, then skyrocketed by 321.67% to $110.9 million in 2020, then skyrocketed by 96.21% to $217.6 million in 2021, then plummeted by 46.78% to $115.8 million in 2022, then plummeted by 63.04% to $42.8 million in 2023.
  • Per Business Quant, the three most recent readings for ARWR's Long-Term Investments are $42.8 million (Q2 2023), $78.8 million (Q1 2023), and $115.8 million (Q4 2022).